Commission de la transparence (June 2012). "Drugs for Alzheimer's disease: best avoided. No therapeutic advantage". Prescrire International21 (128): 150. PMID22822592.
Brookmeyer R, Gray S, Kawas C (September 1998). "Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset". Am J Public Health88 (9): 1337–42. PMC1509089. PMID9736873.
pubmedcentral.gov
Brookmeyer R, Gray S, Kawas C (September 1998). "Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset". Am J Public Health88 (9): 1337–42. PMC1509089. PMID9736873.
